Only healthcare professionals with a Univadis account have access to this article.
You have reached your limit of complementary articles
Free Sign Up Available exclusively to healthcare professionalsEtoricoxib, a COX-2 inhibitor has been linked to a possible increase in risk of coronary and cerebrovascular thrombotic events, heart failure, hypertension, and oedema. GI perforation, ulceration, or bleeding are other risks to be considered with etoricoxib therapy.
Trial results have shown that the 60-mg dose is effective...
account